Keywords: pfizer, initiates, ph, iii, sutent, trial, nsclc

Pfizer initiates Ph III Sutent trial in NSCLC

Article | 17 September 2007

Print This

US drug giant Pfizer says it has initiated a global Phase III evaluation of Sutent (sunitinib malate) in combination with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in